Ontrak (OTRKQ)
OTHER OTC:OTRKQ
Top Page
Ontrak
(OTC:OTRKQ)
Select Model
Select Model
Rating:44Neutral
Price Target:
$0.00
▼(-100.00% Downside)
Action:UpgradedDate:10/23/25
Ontrak's overall stock score of 44 is driven primarily by its weak financial performance, with declining revenue, heavy losses, high debt, and negative cash flows posing significant risks. Technical analysis shows mixed signals with a long-term downtrend, while valuation metrics highlight unprofitability and lack of shareholder returns. Financial health remains the most critical concern impacting the score.
Positive Factors
Strategic Partnerships
Strategic partnerships with health insurers expand Ontrak's market reach and service offerings, potentially driving long-term revenue growth and enhancing competitive positioning in the healthcare technology sector.
Negative Factors
Declining Revenue
Declining revenue indicates potential market challenges and operational inefficiencies, which could hinder growth and profitability if not addressed through strategic adjustments.
Read all positive and negative factors
Positive Factors
Negative Factors
Strategic Partnerships
Strategic partnerships with health insurers expand Ontrak's market reach and service offerings, potentially driving long-term revenue growth and enhancing competitive positioning in the healthcare technology sector.
Read all positive factors
Ontrak (OTRKQ) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.42K
Dividend YieldN/A
Average Volume (3M)103.21K
Price to Earnings (P/E)―
Beta (1Y)-93.05
Revenue Growth-21.03%
EPS Growth47.41%
CountryUS
Employees104
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding7,084,537
10 Day Avg. Volume63,585
30 Day Avg. Volume103,209
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.84
Price to Sales (P/S)0.77
P/FCF Ratio-0.61
Enterprise Value/Market Cap3.95K
Enterprise Value/Revenue0.55
Enterprise Value/Gross Profit0.95
Enterprise Value/Ebitda-0.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-2.32
Revenue Forecast (FY)$22.12M
Ontrak Business Overview & Revenue Model
Company Description
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to health plans and other third-party payors in the United States. Its technology-enabled platform...
How the Company Makes Money
Ontrak generates revenue primarily through contracts with health plans and employers, where it provides its behavioral health intervention programs. The company's revenue model is based on a fee-for-service structure, often incorporating performan...
Ontrak Earnings Call Summary
Earnings Call Date:May 20, 2025
(Q1-2025)
| % Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Neutral
The earnings call reflects a mixed sentiment with significant operational improvements and growth in membership contrasted by a notable decline in revenue and gross margin due to customer loss. While there are promising new business opportunities, the financial challenges remain a concern.Positive Updates
Expansion of Outreach Pool
Ontrak's outreach pool has expanded significantly over the past year with new customer implementations, including Intermountain Health and a Northeast regional plan.
Negative Updates
Revenue Decline
Q1 2025 revenue was $2 million, reflecting a 25% decrease compared to the same period last year due to the loss of a major customer.
Read all updates
Q1-2025 Updates
Positive
Negative
Expansion of Outreach Pool
Ontrak's outreach pool has expanded significantly over the past year with new customer implementations, including Intermountain Health and a Northeast regional plan.
Read all positive updates
Company Guidance
During the Ontrak Health First Quarter 2025 Earnings Conference Call, the company provided optimistic guidance regarding its future prospects. Ontrak anticipates doubling its run rate revenue in 2025 compared to 2024, driven by successful conversions of new customer opportunities, notably with a large Midwestern Medicaid plan. The company reported a significant increase in enrolled members, reaching 3,165 by the end of Q1, which nearly doubled year-over-year. The quarter's revenue was $2 million, reflecting a 25% decrease from the previous year, attributed to the loss of a customer at the end of 2024. However, the company expects Q2 2025 revenues to range from $2.2 million to $2.6 million, representing an 8% to 22% sequential increase. Ontrak's strategic investments in AI-driven technology and expanded solution offerings, including the Engage program, have significantly improved productivity and market reach, with the potential to address critical gaps in the behavioral health care landscape. The company also highlighted its strong pipeline of prospective contracts that could bring an additional $15 million in revenue, potentially doubling its current customer-based revenue.Ontrak Financial Statement Overview
Summary
Income Statement
15
Very Negative
Balance Sheet
20
Very Negative
Cash Flow
10
Very Negative
| Breakdown | Mar 2025 | Mar 2024 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.85M | 12.74M | 14.51M | 84.13M | 82.84M |
| Gross Profit | 6.82M | 8.80M | 7.05M | 52.92M | 39.23M |
| EBITDA | -22.59M | -14.42M | -42.38M | -24.65M | -14.21M |
| Net Income | -25.49M | -27.92M | -51.57M | -37.14M | -22.71M |
Balance Sheet | |||||
| Total Assets | 21.07M | 19.85M | 25.76M | 93.68M | 144.70M |
| Cash, Cash Equivalents and Short-Term Investments | 5.71M | 9.70M | 5.03M | 58.82M | 86.91M |
| Total Debt | 8.50M | 1.69M | 11.26M | 37.45M | 48.73M |
| Total Liabilities | 11.21M | 5.58M | 20.08M | 48.13M | 83.95M |
| Stockholders Equity | 9.87M | 14.27M | 5.68M | 45.55M | 60.75M |
Cash Flow | |||||
| Free Cash Flow | -13.61M | -15.78M | -25.12M | -30.64M | -8.04M |
| Operating Cash Flow | -13.44M | -15.50M | -23.97M | -26.16M | -6.28M |
| Investing Cash Flow | -177.00K | -285.00K | -1.16M | -4.48M | -4.64M |
| Financing Cash Flow | 9.62M | 15.77M | -31.11M | -6.63M | 100.11M |
Ontrak Risk Analysis
Ontrak disclosed 61 risk factors in its most recent earnings report. Ontrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Ontrak Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | $949.07M | -6.16 | -14.24% | ― | -2.37% | 77.85% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $88.39M | -0.82 | -35.88% | ― | 4.33% | 50.50% | |
46 Neutral | $152.81M | -2.20 | -47.69% | ― | -5.30% | 46.01% | |
44 Neutral | $1.42K | >-0.01 | ― | ― | -21.03% | 47.41% | |
42 Neutral | $11.02M | -0.51 | 336.68% | ― | 187.24% | 82.90% |
* Healthcare Sector Average
OTRKQ
Ontrak
0.06
-1.45
-96.03%
TDOC
Teladoc
5.32
-2.56
-32.49%
AMWL
American Well
5.34
-1.83
-25.52%
DH
Definitive Healthcare Corp
1.07
-1.42
-57.03%
EUDA
EUDA Health Holdings
7.09
-63.11
-89.90%
VSEE
VSee Health
0.23
-0.93
-80.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.